Assessment of the Effects of Abrocitinib on the Pharmacokinetics of Probe Substrates of Cytochrome P450 1A2, 2B6 and 2C19 Enzymes and Hormonal Oral Contraceptives in Healthy Individuals.
Xiaoxing WangMartin E DowtySakambari TripathyVu H LeYeamin HuhMadelyn CurtoJennifer A WintonMelissa T O'GormanGary ChanBimal K MalhotraPublished in: European journal of drug metabolism and pharmacokinetics (2024)
ClinicalTrials.gov registration IDs: NCT03647670, NCT05067439, NCT03662516.